Skip to content

Menopause

Current BC and Canadian guidelines, algorithms, tools, prescribing references and patient resources for nurse practitioners.

Reviewed by Joe Grafe Due

Key Sources

BC Provincial Academic Detailing - Medications for Menopause-Associated Vasomotor and Genitourinary Symptoms (2026)

BC Ministry of Health pharmacist-led education on oral, transdermal and vaginal estrogens and progestogens, fezolinetant and transdermal testosterone. There is no BC Guideline on menopause.

SOGC - Menopause Clinical Practice Guideline No. 422, seven chapters (2021)

Society of Obstetricians and Gynaecologists of Canada, with the Canadian Menopause Society. Open access in JOGC; replaced the 2014 Managing Menopause guideline. No newer SOGC menopause guideline as of November 2026.

Further Resources

Ontario Health quality standard - Menopause: Care for Women and Gender-Diverse People (2025)

Canada's first menopause quality standard (Ontario): six quality statements on identifying, assessing and managing symptoms.

BC Women's Hospital - Menopause Resources for Health Professionals

BC Women's Hospital + Health Centre (PHSA): tools, recorded webinars and printable guides

BC Medical Journal - Managing Menopause: two-part review of the 2021 SOGC guideline

BCMJ 2022;64(8).

Canadian Menopause Society - Publications for Professionals

National menopause society, co-publisher of the SOGC Menopause Hub.

Centre for Effective Practice - Menopause Management (2025)

Ontario primary care tool from perimenopause to postmenopause: menopausal hormone therapy risk assessment and shared decisions.

Canadian Family Physician and CMAJ articles
International: AAFP - Managing Menopausal Symptoms: Common Questions and Answers (2023)

International source: American review, not Canadian. American Family Physician 2023;108(1):28-39, free to read; updated online for fezolinetant.

International: International Menopause Society (IMS) Recommendations on Women's Midlife Health and Menopause (2025)

International source: global society guideline, not Canadian. GRADE-rated recommendations from lifestyle and vasomotor symptoms to POI, osteoporosis and cancer.

International: The Menopause Society - Position Statements

International source: North American (US-based) society, not Canadian. Each statement has a patient handout (MenoNote).

International: NICE - Menopause: Identification and Management (NG23) (2026)

International source: UK guidance, not Canadian. Published 2015, last updated April 15, 2026.

Algorithms and Pathways

Alberta's Menopause and Perimenopause pathway was updated in January 2026 and its Post-Menopausal Bleeding pathway is under scheduled review (the hub's New & upcoming list, checked November 6, 2026). The BC pathways above are adapted from them.

Assessment Tools and Calculators

Prescribing

RxFiles - Menopause (2025)

RxFiles (University of Saskatchewan) guide to menopause management in primary care. The documents need an RxFiles subscription.

  • Canadian Menopause Society - MHT Tables (2025) · PDF — menopausal hormone therapy products available in Canada, tables 1 to 7
  • Canadian Menopause Society - Systemic MHT Equivalency Table (2025) · PDF — equivalent doses across systemic estrogen products
Non-hormonal drugs for vasomotor symptoms: evidence summaries

Advice and Referral

BC Women's Hospital - Complex Menopause Clinic Referral

Provincial clinic, virtual and in person, for severe or complex menopause; eligibility and exclusion criteria are on the page. Referral from a physician or nurse practitioner.

Patient Resources